Introduction
Pain is one of the most frequently reported symptoms for children undergoing cancer treatment. 1 The causes of pain are commonly the disease itself, side effects of treatment and medical procedures. 2 Pain is associated with psychological distress for the children, and this in turn increases the pain experience. [3] [4] [5] [6] [7] Psychological acceptance has been shown to be beneficial for persons suffering from chronic pain. [8] [9] [10] Psychological acceptance of chronic pain is defined as living with pain without reacting to, judging or attempting to reduce or avoid it. 11 It involves an active willingness to engage in meaningful activities in the presence of pain in the service of living a vital valued life. An acceptance-based psychological treatment, acceptance and commitment therapy (ACT), has been shown to improve psychosocial and physical functioning in adults and children with chronic pain. 12, 13 ACT aims to create psychological flexibility around
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Thorsell Cederberg et al difficult experiences to enable moving forward in life as opposed to getting stuck in avoidant behavior. 14 In the ACT model, acceptance is one of the processes underpinning psychological flexibility. For pain that has been experimentally induced, different acceptance-based interventions have been shown to predict increased pain tolerance and decreased pain intensity and experienced unpleasantness of pain. [15] [16] [17] [18] [19] [20] [21] [22] The common denominator of these interventions is the cultivation of an attentive, non-reactive stance toward unpleasant stimuli with the aim to merely observe ongoing experiences without further mental processing in contrast to attempting to control or distract, corresponding to the process of acceptance. 23, 24 A pilot study of an acceptance-based intervention for children experiencing pain during cancer treatment is currently being undertaken at the Children's University Hospital in Uppsala, Sweden, showing promising results (J Thorsell Cederberg, MS, unpublished data, October 2016). Psychological acceptance is the proposed mechanism of change in the intervention. Studying and understanding mechanisms of change in the evaluation of therapeutic interventions guides optimization of treatment change. 25 Several instruments measuring acceptance in chronic pain have been reported. [26] [27] [28] To date, no instrument for measuring acceptance in the context of acute pain has been reported. The development of such an instrument would enable the investigation of acceptance as a possible mediating variable of acceptance-based interventions for those experiencing acute pain.
The role of the parent in interventions targeting children has been emphasized regarding both pediatric cancer 29 and pediatric pain. 30 Having a child undergoing cancer treatment infers a great deal of psychological distress for parents. [31] [32] [33] Parent distress and behavior affect levels of distress and coping in the child, [34] [35] [36] [37] [38] [39] and parental acceptance has been shown to predict lower levels of child distress. 40, 41 Developing and evaluating an instrument measuring parental acceptance would be helpful in investigating the mediating processes of psychological treatments targeting acute pain in children.
In summary, acceptance-based interventions could potentially help children experiencing pain during cancer treatment. The evaluation of acceptance as the mediating variable of such an intervention is dependent on an instrument for measuring acceptance of acute pain. Further, since parental acceptance may affect child distress and coping, an instrument for measuring this is essential. The aim of this study was to develop an instrument to measure parental acceptance in the context of acute pain in children with cancer.
Methods

Participants and procedures
The target population was parents of all children aged 0-18 years, being treated for cancer in Sweden at the time of the study. Children undergoing cancer treatment were identified by the Swedish Childhood Cancer Registry. Four hundred and eighty-five patients were identified. In one case, patient information was insufficient and the patient was therefore excluded. The six pediatric oncology centers in Sweden were consulted to ensure that parents of children who had gone into palliation or deceased after data withdrawal from the register were not contacted. One patient was then identified as undergoing palliation and therefore excluded as a result of this screening. Parents of 483 children were thus contacted and offered participation in the study. Information about the study along with two sets of the study material was sent out via mail to the registered address. As thanks for their participation in the study, the parents were included in a lottery of ten movie tickets. Consent was implied by participation in the study. The study material consisted of background information, the test version of the acceptance scale, evaluation questions and two measures for validation. A reminder was sent out 2 weeks after the first dispatch. For test-retest analysis, the measures were sent out again after a month. All study material was coded and hence de-identified. A code key was kept during data collection for administrative purposes. Two hundred and forty-six parents participated in the study of which 117 parents participated in both measurements and 129 participated in only one measurement. Parents of 160 children participated in the study, which corresponds to 34% of the children. For 85 of the children, both parents responded, for 75 one parent responded. Three were excluded due to incorrect completion of the measures. Two parents only filled in the background information and one of the validation measures at the first measurement, and hence not the test scale, and were not sent the test-retest material. One parent filled in the first measurement (M1) jointly with the other parent, which led to exclusion of that measurement, and did not fill in the test-retest measurement (M2), which the other parent did. Three other couples filled in M1 conjointly, and these measurements were excluded, but M2 was filled in separately and hence valid. Two hundred and forty-three participants were included in the analyses. Twenty-five parents (of 23 children) declined. Nine dispatches were returned by the postal service. No response was received from parents of 205 children. Two test-retest measurements came in 8 months late and were not included in the study. Figure 1 
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Parents' relationship to pain during children's cancer treatment Table 1 . The study was approved by the Regional Ethical Committee in Uppsala, Sweden (Dnr 2014/375).
Background information
Background information included relationship to the child, age and gender of the child, type and date of diagnosis, date of end of treatment (if ended), current pain and discomfort, highest, lowest and average level of pain during the past week, average level of discomfort of pain during the past week and type of pain.
Development of the Pain Flexibility Scale for Parents (PFS-P)
Three psychologists acquainted with the concept of acceptance, both theoretically and clinically, were involved in the development process. A sketch of possible dimensions of acceptance in the context of pediatric cancer pain was formed. The basic structure of the Swedish version of the Chronic Pain Acceptance Questionnaire (CPAQ) was used in the development of the new scale. 26, 42 The CPAQ is a 20-item self-report questionnaire for measuring acceptance in patients with chronic pain. It consists of two subscales, the Activity Engagement scale (11 items), which measures engagement in meaningful activities in the presence of pain, and the Pain Willingness scale (nine items), which measures willingness to experience pain and the degree to which the respondent tries to avoid or control pain. Higher scores indicate a higher level of acceptance. Cronbach's alpha of the CPAQ has been shown to be 0.78-0.82, and it correlates negatively with measures of physical disability and psychological ill health. All items from the CPAQ with a clear chronic pain orientation, such as "I lead a full life even though I have chronic pain", were deleted. These were #2, #4, #5, #6, #9, #10, #12, #13, #14, #18 and #19. Nine items from the CPAQ were kept but re-formulated to capture the process of acceptance in the context of acute pain in children with cancer. These were #1, #3, #7, #8, #11, #15, #16, #17 and #20. For example, item 3 from the CPAQ "It's OK to experience pain" was altered to "Sometimes it feels ok for me when my child is pain", and item 11 "My thoughts and feelings about pain must change before I can take important steps in life" was altered to "My child's pain needs to pass before I can focus on anything else". Other, new items (28) were created, guided by the preliminary sketch of dimensions. A preliminary test version of the scale was handed out to two parents of children with cancer and four "lay" parents. Some items were adjusted according to this feedback. The final test version included 37 items. A seven-point Likert scale was used, where items were rated on a scale from 0="Completely disagree" to 6="Entirely agree". Twenty-two items were reversed for the statistical analyses.
Measures used for validation
The Pain Catastrophizing Scale for Parents (PCS-P) and the Acceptance and Action Questionnaire (AAQ-II) were used to assess convergent validity. The PCS-P is a 13-item scale designed to measure catastrophizing thoughts in parents of children with pain. 43, 44 Respondents rate their level of agreement with statements such as "When my child is in pain, I worry all the time about whether the pain will end" and "When my child is in pain, I keep thinking about how badly I want the pain to stop" on a five-point Likert scale. Higher scores indicate a higher level of catastrophizing. Cronbach's alpha for the PCS-P has been shown to be 0.93, and the scale correlates with measures of parental distress 
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Thorsell Cederberg et al and child functioning and disability. The AAQ-II is designed to measure a general level of experiential avoidance. 45, 46 Participants rate their level of agreement with statements such as "I'm afraid of my feelings" and "I worry about not being able to control my worries and feelings" on a sevenpoint Likert scale. Higher scores indicate a higher level of experiential avoidance. Cronbach's alpha for the AAQ-II has been shown to be 0.78-0.88, test-retest reliability over 3 months has been shown to be 0.81 and the scale correlates with a range of measures of mental health. The short version of six items was used. 47 
Statistical analyses
All statistical analyses were performed in IBM SPSS Statistics, version 20. 48 Additionally, the Monte Carlo PCA program was used for parallel analysis. 49 Initial analyses of the original test scale of 37 items were performed. Internal consistency was calculated to assess the appropriateness of factor analysis. Frequency distributions were examined to identify items that did not show sufficient variability in responses. Inter-item and item-total correlations were examined to identify items that did not correlate sufficiently with the other items and/or the total questionnaire. Intraclass correlation (ICC) was calculated to examine possible dependence in data between pairs. 50 A one-way random model was used assessing the single measures value. 51 An ICC of <0.40 indicates poor inter-rater agreement, between 0.40 and 0.59 fair, between 0.60 and 0.74 good and >0.75 excellent. 52 Preliminary factor analysis was carried out and eigenvalue, scree plot, parallel analysis and pattern matrices were evaluated to select the number of factors for final analysis. Factor analysis was performed in the form of principal component analysis (PCA). Internal consistency and test-retest reliability were calculated for the total scale (Pearson) and the subscales (Spearman's rho). Correlations with other measures were performed to assess convergent validity (Spearman's rho). Correlation coefficients were interpreted according to Cohen, 53 where r=0.10-0.29 was considered small, 0.30-0.49 medium and 0.5-1.0 large. For seven participants, only the M2 was valid. For statistical reasons, these were analyzed pertaining to M1.
Results
Descriptives
The data from 243 parents of 158 children were included in the statistical analyses. Table 2 shows parents' reports of their children's level of pain. Regarding type of pain, at M1 (n=185), seven parents reported pain due to the illness, 70 due to side effects of treatment, 16 due to medical procedures, 14 other type of pain and 78 reported pain due to several medical causes. At M2 (n=63), six parents reported pain due to the illness, 24 due to side effects of treatment, six due to medical procedures, six reported other type of pain and 21 reported pain due to several medical causes.
Factor analysis
Outliers were identified on items 2 and 22 and on the total scale. Given that there was very little difference between the mean and the trimmed mean, outliers were kept in the analyses. Frequency distributions showed that items 9, 13, 24 and 36 had somewhat limited variability. This was, however, considered acceptable. Internal consistency of the original 37-item scale was good (α=0.87). Twelve items had low corrected item-total correlations (<0.3) and were eliminated from further analysis. These were 1) "I brace myself when my child is in pain"; 12) "By thinking about something else I can handle the worry over my child being in pain"; 16) "I encourage my child to avoid movements or situations that might increase the pain"; 19) "Sometimes I feel that I am greater than my worries"; 20) "My worry is easier when I try to control it"; 22) "I react to my child's pain differently from one time to another"; 23) "If grit my teeth I can stand my child being in pain"; 26) "Sometimes it's unavoidable that my child experiences pain"; 32) "I try to help myself to Bartlett's test of sphericity was significant, the Kaiser-Meyer-Olkin (KMO) index was 0.91 and preliminary factor analyses showed no items that consistently loaded independently of the others. PCA was carried out on the remaining 25 items. Correlations between factors indicated interdependence between factors, and oblique rotation was used. The preliminary factor analyses extracted four factors with eigenvalues >1. Variance explained by a four-factor solution was 61%. The scree plot showed a somewhat ambiguous result with an elbow at factors 2 and 4, indicating either one or three factors to retain. Parallel analysis indicated three factors to retain, while the component matrix indicated a twofactor solution. Further, the pattern matrix and the theoretical coherence between items were evaluated. Taken together, a three-factor solution with Promax rotation was chosen. Variance explained by a three-factor solution was 56%; 39% by the first, 10% by the second factor and 7% by the third factor. All but two items (5 and 25) had factor loadings >0.4, and all but one item (5) had communalities >0.3. On considering both low factor loading and low communality, item 5, "It is impossible for me to do anything when my child is in pain", was then eliminated. Hence, 24 items were included in the final solution. The theoretical analysis of the factors and their items yielded the following factor labels: 1) pain resistance, 2) valued action and 3) pain fusion. The first factor, pain resistance, is characterized by resisting, avoiding or attempting to control the feelings that having a child in pain implies. It also includes a kind of reactivity to their child's pain where the pain is seen as a threat and something that is impossible to live with. The second factor, valued action, is characterized by continuing to do things simultaneously while worrying over the child's pain, a way to live in the presence of pain and worry. The third factor, pain fusion, is characterized by evaluative language processing and rule-governed verbal behavior about pain, ie, judgments and verbal rules about pain itself and how it affects oneself and/or the child, and a literalization (ie, fusion) of these language processes. Note that for two items in factor 2 and one item in factor 3, the items represent the opposite pole of that factor compared to the other items. Table 3 shows the final factor solution. The score range is 0-144 for the total scale, 0-54 for the pain Reliability and validity Table 4 shows the mean, standard deviation, range (minimum-maximum), internal consistency and correlation coefficients for the total scale and the subscales. All correlation coefficients were large, except the coefficient between the pain fusion subscale and the AAQ-II that was medium. All correlations were significant (p<0.01). All correlations were also calculated controlling for level of pain and change in level of pain, which had no or little effect on the correlations.
Discussion
The aim of this study was to develop and preliminarily evaluate an instrument to measure acceptance in parents of children experiencing pain during cancer treatment. A test version was developed based on theoretical considerations and the CPAQ. 26 Factor analysis showed that a three-factor solution best represented the data. The final scale, the PFS-P, consisted of 24 items. The three subscales were pain resistance, valued action and pain fusion. Based on the theoretical analysis of the subscales, the term "Flexibility" was chosen instead of "Acceptance" for the total scale to indicate the somewhat greater width of the scale, including the subscales valued action and pain fusion. The total scale and the subscales all showed good internal reliability, temporal stability and good convergent validity. A fair sample for factor analysis was achieved with 243 respondents.
Parents of all children undergoing cancer treatment at the time of the study were offered participation in the study. To gain information regarding the pain status of the child, respondents were asked to rate their child's level of pain. For many respondents, their child had previously experienced pain but was not in pain at the time of study. In those cases, the measurements were completed retroactively. This can explain the low mean pain level. Despite the sub-optimal nature of retroactive measurements, the ratings were considered valid, taking into consideration the presumably strong experience of having a child in pain. Respondents were not asked about whether the child had previously experienced pain. Such a question would clearly have added important information. In the absence of such a control question, there was a risk of collecting data from parents whose children had not experienced pain during cancer treatment. Previous research 1 and clinical experience suggest, however, that with few exceptions, this would be an unlikely scenario. Further, the comments provided by the respondents who did not report any current pain revealed that their children had previously experienced pain. The risk of including "non-pain-respondents" in the study is therefore considered small. For those who explicitly declined participation, what was often given as a reason for declining was that the child had not experienced any pain during his/her treatment or that the pain was very limited in time or intensity. Again, considering previous research 1 and clinical experience, the latter scenario would be more plausible.
Parents of one-third of the children participated in the study. Bearing in mind the often stressful and intense situation that undergoing cancer treatment brings about for these families, not responding to scientific studies is understandable. Expectations of a higher answering frequency may therefore be unrealistic. This is, however, something to keep in mind when generalizing the results of the study.
A frequent comment from respondents was that the source, type and level of pain considerably affected their ability to cope with it. It is not hard to imagine that if the source of the pain is known and/or the pain is benign, it is easier to accept and to stay psychologically flexible, whereas if the source of the pain is unknown and/or malignant, it gets harder. Parents of young and/or disabled children expressed a particular worry about not knowing how much pain their child experienced and whether the child was getting appropriate pain medication or not. Further, many respondents commented that they experienced a lack of psychosocial support during the treatment, that they were left alone with difficult feelings. Interventions naturally need to be tailored according to these experiences of the children and the parents.
This study is a preliminary validation of the PFS-P, and further validation is important, particularly if the scale is to be used for other populations. Note also that a Swedish Table 4 Mean, SD, score range, internal consistency and correlation coefficients for the total scale and the subscales version of the scale was developed and evaluated. An English version therefore needs to be validated. Further, sensitivity to change needs to be assessed.
Conclusion
A psychometrically sound scale for measuring acceptance in parents of children experiencing pain during cancer treatment is now available for use. This enables evaluating acceptancebased interventions targeting both parents and children in the context of pain in children with cancer. This in turn is a way to optimize interventions that may help both parents and children cope better in these difficult circumstances.
